These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25117799)

  • 1. Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1.
    Siliciano JD; Siliciano RF
    J Allergy Clin Immunol; 2014 Jul; 134(1):12-9. PubMed ID: 25117799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of extravascular reservoirs of latent infection for HIV persistence during antiretroviral therapy.
    Sundstrom JB
    J Allergy Clin Immunol; 2015 Jul; 136(1):213. PubMed ID: 25979519
    [No Abstract]   [Full Text] [Related]  

  • 4. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.
    Shan L; Siliciano RF
    Bioessays; 2013 Jun; 35(6):544-52. PubMed ID: 23613347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Latent Reservoir for HIV-1.
    Sengupta S; Siliciano RF
    Immunity; 2018 May; 48(5):872-895. PubMed ID: 29768175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence.
    Murray AJ; Kwon KJ; Farber DL; Siliciano RF
    J Immunol; 2016 Jul; 197(2):407-17. PubMed ID: 27382129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging race to cure HIV infections.
    Cohen J
    Science; 2011 May; 332(6031):784-5, 787-9. PubMed ID: 21566173
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir.
    Suryawanshi P; Bagul R; Shete A; Thakar M
    Front Immunol; 2021; 12():663919. PubMed ID: 33995393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
    Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
    J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation.
    Xing S; Bullen CK; Shroff NS; Shan L; Yang HC; Manucci JL; Bhat S; Zhang H; Margolick JB; Quinn TC; Margolis DM; Siliciano JD; Siliciano RF
    J Virol; 2011 Jun; 85(12):6060-4. PubMed ID: 21471244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which therapeutic strategy will achieve a cure for HIV-1?
    Cillo AR; Mellors JW
    Curr Opin Virol; 2016 Jun; 18():14-9. PubMed ID: 26985878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
    Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
    Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peering into the HIV reservoir.
    García M; Buzón MJ; Benito JM; Rallón N
    Rev Med Virol; 2018 Jul; 28(4):e1981. PubMed ID: 29744964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.
    Laird GM; Rosenbloom DI; Lai J; Siliciano RF; Siliciano JD
    Methods Mol Biol; 2016; 1354():239-53. PubMed ID: 26714716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
    Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
    J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply: To PMID 25117799.
    Siliciano JD; Siliciano RF
    J Allergy Clin Immunol; 2015 Jul; 136(1):214. PubMed ID: 25979523
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.
    Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK;
    J Virol; 2014 Mar; 88(6):3516-26. PubMed ID: 24403590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to HIV Cure.
    Stein J; Storcksdieck Genannt Bonsmann M; Streeck H
    HLA; 2016 Oct; 88(4):155-63. PubMed ID: 27620852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Infection: Advances Toward a Cure.
    Douek DC
    Top Antivir Med; 2018 Apr; 25(4):121-125. PubMed ID: 29689537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding a cure for human immunodeficiency virus-1 infection.
    Blankson JN; Siliciano JD; Siliciano RF
    Infect Dis Clin North Am; 2014 Dec; 28(4):633-50. PubMed ID: 25277513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.